vs
NOVAVAX INC（NVAX）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
NOVAVAX INC的季度营收约是RESOURCES CONNECTION, INC.的1.3倍（$147.3M vs $117.7M），NOVAVAX INC净利率更高（11.9% vs -10.8%，领先22.6%），NOVAVAX INC同比增速更快（66.8% vs -19.2%），RESOURCES CONNECTION, INC.自由现金流更多（$15.6M vs $-41.6M），过去两年NOVAVAX INC的营收复合增速更高（25.3% vs -11.8%）
诺瓦瓦克斯是一家总部位于美国马里兰州盖瑟斯堡的生物科技企业，专注于传染病疫苗研发。其开发的新冠疫苗现由赛诺菲负责商业化，同时还在布局流感、呼吸道合胞病毒（RSV）、禽流感、带状疱疹、艰难梭菌感染、疟疾等多个领域的疫苗管线。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
NVAX vs RGP — 直观对比
营收规模更大
NVAX
是对方的1.3倍
$117.7M
营收增速更快
NVAX
高出86.0%
-19.2%
净利率更高
NVAX
高出22.6%
-10.8%
自由现金流更多
RGP
多$57.1M
$-41.6M
两年增速更快
NVAX
近两年复合增速
-11.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $147.3M | $117.7M |
| 净利润 | $17.5M | $-12.7M |
| 毛利率 | 85.0% | 37.1% |
| 营业利润率 | 9.7% | -10.3% |
| 净利率 | 11.9% | -10.8% |
| 营收同比 | 66.8% | -19.2% |
| 净利润同比 | 121.6% | 81.6% |
| 每股收益（稀释后） | $0.28 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVAXRGP
| Q4 25 | $147.3M | $117.7M | ||
| Q3 25 | $70.4M | $120.2M | ||
| Q2 25 | $239.2M | $139.3M | ||
| Q1 25 | $666.5M | $129.4M | ||
| Q4 24 | $88.3M | $145.6M | ||
| Q3 24 | $84.5M | $136.9M | ||
| Q2 24 | $415.5M | $148.2M | ||
| Q1 24 | $93.9M | $151.3M |
净利润NVAXRGP
| Q4 25 | $17.5M | $-12.7M | ||
| Q3 25 | $-202.4M | $-2.4M | ||
| Q2 25 | $106.5M | $-73.3M | ||
| Q1 25 | $518.6M | $-44.1M | ||
| Q4 24 | — | $-68.7M | ||
| Q3 24 | $-121.3M | $-5.7M | ||
| Q2 24 | $162.4M | $10.5M | ||
| Q1 24 | $-147.6M | $2.5M |
毛利率NVAXRGP
| Q4 25 | 85.0% | 37.1% | ||
| Q3 25 | 69.5% | 39.5% | ||
| Q2 25 | 93.6% | 40.2% | ||
| Q1 25 | 97.9% | 35.1% | ||
| Q4 24 | 58.5% | 38.5% | ||
| Q3 24 | 28.3% | 36.5% | ||
| Q2 24 | 88.9% | 40.2% | ||
| Q1 24 | 36.9% | 37.0% |
营业利润率NVAXRGP
| Q4 25 | 9.7% | -10.3% | ||
| Q3 25 | -252.7% | -1.7% | ||
| Q2 25 | 42.2% | -47.0% | ||
| Q1 25 | 77.4% | -38.4% | ||
| Q4 24 | — | -52.7% | ||
| Q3 24 | -158.6% | -3.5% | ||
| Q2 24 | 38.7% | 7.6% | ||
| Q1 24 | -154.3% | 2.8% |
净利率NVAXRGP
| Q4 25 | 11.9% | -10.8% | ||
| Q3 25 | -287.3% | -2.0% | ||
| Q2 25 | 44.5% | -52.6% | ||
| Q1 25 | 77.8% | -34.0% | ||
| Q4 24 | — | -47.2% | ||
| Q3 24 | -143.5% | -4.2% | ||
| Q2 24 | 39.1% | 7.1% | ||
| Q1 24 | -157.2% | 1.7% |
每股收益（稀释后）NVAXRGP
| Q4 25 | $0.28 | $-0.38 | ||
| Q3 25 | $-1.25 | $-0.07 | ||
| Q2 25 | $0.62 | $-2.21 | ||
| Q1 25 | $2.93 | $-1.34 | ||
| Q4 24 | — | $-2.08 | ||
| Q3 24 | $-0.76 | $-0.17 | ||
| Q2 24 | $0.99 | $0.31 | ||
| Q1 24 | $-1.05 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $735.1M | $89.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-127.8M | $194.6M |
| 总资产 | $1.2B | $289.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NVAXRGP
| Q4 25 | $735.1M | $89.8M | ||
| Q3 25 | $762.9M | $77.5M | ||
| Q2 25 | $612.3M | $86.1M | ||
| Q1 25 | $731.5M | $72.5M | ||
| Q4 24 | $923.1M | $78.2M | ||
| Q3 24 | $909.5M | $89.6M | ||
| Q2 24 | $1.0B | $108.9M | ||
| Q1 24 | $480.6M | $113.8M |
股东权益NVAXRGP
| Q4 25 | $-127.8M | $194.6M | ||
| Q3 25 | $-156.7M | $206.4M | ||
| Q2 25 | $37.6M | $207.1M | ||
| Q1 25 | $-75.6M | $277.8M | ||
| Q4 24 | $-623.8M | $325.7M | ||
| Q3 24 | $-526.4M | $407.2M | ||
| Q2 24 | $-431.7M | $418.8M | ||
| Q1 24 | $-867.1M | $414.9M |
总资产NVAXRGP
| Q4 25 | $1.2B | $289.3M | ||
| Q3 25 | $1.2B | $287.2M | ||
| Q2 25 | $1.3B | $304.7M | ||
| Q1 25 | $1.3B | $375.6M | ||
| Q4 24 | $1.6B | $424.9M | ||
| Q3 24 | $1.7B | $512.9M | ||
| Q2 24 | $1.8B | $510.9M | ||
| Q1 24 | $1.4B | $523.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-39.5M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $-41.6M | $15.6M |
| 自由现金流率自由现金流/营收 | -28.2% | 13.2% |
| 资本支出强度资本支出/营收 | 1.4% | 0.3% |
| 现金转化率经营现金流/净利润 | -2.25× | — |
| 过去12个月自由现金流最近4个季度 | $-250.2M | $24.3M |
8季度趋势，按日历期对齐
经营现金流NVAXRGP
| Q4 25 | $-39.5M | $15.9M | ||
| Q3 25 | $107.8M | $-7.8M | ||
| Q2 25 | $-127.5M | $16.8M | ||
| Q1 25 | $-185.5M | $659.0K | ||
| Q4 24 | $-87.3M | $1.8M | ||
| Q3 24 | $-144.8M | $-309.0K | ||
| Q2 24 | $314.3M | $3.2M | ||
| Q1 24 | $-83.6M | $20.5M |
自由现金流NVAXRGP
| Q4 25 | $-41.6M | $15.6M | ||
| Q3 25 | $105.8M | $-8.0M | ||
| Q2 25 | $-127.7M | $16.5M | ||
| Q1 25 | $-186.7M | $238.0K | ||
| Q4 24 | $-100.3M | $61.0K | ||
| Q3 24 | $-146.2M | $-575.0K | ||
| Q2 24 | $311.4M | $3.0M | ||
| Q1 24 | $-90.4M | $20.4M |
自由现金流率NVAXRGP
| Q4 25 | -28.2% | 13.2% | ||
| Q3 25 | 150.2% | -6.6% | ||
| Q2 25 | -53.4% | 11.8% | ||
| Q1 25 | -28.0% | 0.2% | ||
| Q4 24 | -113.6% | 0.0% | ||
| Q3 24 | -173.0% | -0.4% | ||
| Q2 24 | 74.9% | 2.1% | ||
| Q1 24 | -96.4% | 13.5% |
资本支出强度NVAXRGP
| Q4 25 | 1.4% | 0.3% | ||
| Q3 25 | 2.9% | 0.1% | ||
| Q2 25 | 0.1% | 0.2% | ||
| Q1 25 | 0.2% | 0.3% | ||
| Q4 24 | 14.8% | 1.2% | ||
| Q3 24 | 1.6% | 0.2% | ||
| Q2 24 | 0.7% | 0.1% | ||
| Q1 24 | 7.3% | 0.1% |
现金转化率NVAXRGP
| Q4 25 | -2.25× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.20× | — | ||
| Q1 25 | -0.36× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.94× | 0.30× | ||
| Q1 24 | — | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVAX
| Licensing Royalties And Other | $107.9M | 73% |
| Products | $39.2M | 27% |
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
